Diffusion Pharmaceuticals... (DFFN)
Diffusion Pharmaceuticals Statistics
Share Statistics
Diffusion Pharmaceuticals has 2.04M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 2.04M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.35M |
| Failed to Deliver (FTD) Shares | 1.51K |
| FTD / Avg. Volume | 3.15% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.02 and the forward PE ratio is null. Diffusion Pharmaceuticals's PEG ratio is 0.02.
| PE Ratio | -1.02 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.77 |
| P/FCF Ratio | -1.03 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Diffusion Pharmaceuticals has an Enterprise Value (EV) of 5.35M.
| EV / Sales | 0 |
| EV / EBITDA | -0.34 |
| EV / EBIT | -0.36 |
| EV / FCF | -0.36 |
Financial Position
The company has a current ratio of 9.36, with a Debt / Equity ratio of 0.
| Current Ratio | 9.36 |
| Quick Ratio | 9.36 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 41.95 |
Financial Efficiency
Return on Equity is -75.23% and Return on Invested Capital is -77.07%.
| Return on Equity | -75.23% |
| Return on Assets | -67.2% |
| Return on Invested Capital | -77.07% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.17M |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -380.75K |
| Effective Tax Rate | 2.44% |
Stock Price Statistics
The stock price has increased by -33.33% in the last 52 weeks. The beta is 1.76, so Diffusion Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 1.76 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 4.99 |
| 200-Day Moving Average | 7.18 |
| Relative Strength Index (RSI) | 78.62 |
| Average Volume (20 Days) | 47.81K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -15.97M |
| Net Income | -15.21M |
| EBITDA | -15.97M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -7.46 |
Balance Sheet
The company has 10.11M in cash and 0 in debt, giving a net cash position of 10.11M.
| Cash & Cash Equivalents | 10.11M |
| Total Debt | 0 |
| Net Cash | 10.11M |
| Retained Earnings | -145.6M |
| Total Assets | 12.04M |
| Working Capital | 10.76M |
Cash Flow
In the last 12 months, operating cash flow was -14.97M and capital expenditures 0, giving a free cash flow of -14.97M.
| Operating Cash Flow | -14.97M |
| Capital Expenditures | 0 |
| Free Cash Flow | -14.97M |
| FCF Per Share | -7.34 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DFFN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -98.34% |
| FCF Yield | -96.78% |
Analyst Forecast
Currently there are no analyst rating for DFFN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 2:3.
| Last Split Date | Aug 17, 2023 |
| Split Type | backward |
| Split Ratio | 2:3 |
Scores
| Altman Z-Score | 1786.86 |
| Piotroski F-Score | 1 |